New Product Planning

pharmaceutical new product planning

Our blend of clinical development experience, marketing toolbox and therapeutic expertise uniquely positions our team to support the pharmaceutical new product planning and development process. We have a long history of assisting clients in developing and implementing strategies that ensure differentiation and maintained product access for patients. Our success is driven by a deep understanding of the nuances of relevant markets and products which informs realistic, targeted and data-driven recommendations.

Herspiegel Consulting delivers strategic assessments and insightful processes in new product planning thus creating a structure for decision making. We help advance the development process with actionable insights to evaluate market potential, prioritize launch markets and develop competitive lifecycle management plans.

Recent Projects Include:

  • • Market landscape assessment and opportunity sizing

  • • Global disease strategy at corporate, BU and asset level strategy

  • • Early assets management including stage gate decision support

  • • Launch prioritization

  • • Creation of a dynamic forecast model

  • • Investor deck development

  • • Lifecycle management plan

Latest Blogs

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...
Read more

Why Drug Pricing is in the News Now and What Can Be Done About It?

March 3, 2017
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan,...
Read more

Key Challenges Facing Obamacare Repeal and Replace Plan

February 3, 2017
ACA repeal and replacement complicated by two key challenges...
Read more

How Pharma Can Prepare for the Patent Cliff

February 2, 2017
Extending market exclusivity and responding properly to the volume of recent patent expiries are critica...
Read more